Erk1/2 is not required for endothelial barrier establishment despite its requirement for cAMP-dependent Rac1...

Area of Science:

• Cardiovascular Biology
• Cell Signaling
• Endothelial Function

Background:

• The role of Erk1/2 in endothelial barrier regulation is complex and varies across different vascular beds.
• Understanding Erk1/2's interaction with cAMP-dependent pathways is key to modulating endothelial barrier integrity.

Purpose of the Study:

• To investigate the impact of Erk1/2 inhibition on endothelial barrier maintenance in myocardial endothelial cells (MyEnd).
• To explore the relationship between Erk1/2 activity and cAMP-mediated barrier strengthening.

Main Methods:

• Myocardial endothelial cells (MyEnd) isolation and analysis of protein expression, localization, and activity.
• Western blot, immunostaining, and G-LISA for molecular analysis.
• Measurement of transendothelial electrical resistance (TEER) for in vitro barrier integrity.
• In vivo Miles assay for vascular permeability assessment.

Main Results:

• Erk1/2 inhibition did not alter the structural organization or protein levels of tight and adherens junctions.
• U0126 treatment caused a transient drop in TEER, indicating a temporary loss of barrier function.
• Erk1/2 inhibition delayed, but did not abolish, cAMP-induced barrier strengthening and reduced Rac1 activation.
• Inhibition of Erk1/2 induced vascular leakage in vivo, which was preventable by local cAMP elevation.

Conclusions:

• Erk1/2 signaling is essential for preventing vascular permeability in myocardial endothelial cells.
• Erk1/2 is not critical for the cAMP-mediated enhancement of the endothelial barrier.
• Targeting Erk1/2 may offer therapeutic potential for conditions involving vascular leakage.